Contact Us
Automation In Biopharma Industry Global Market Report 2025
Global Automation In Biopharma Industry Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Automation In Biopharma Industry Global Market Report 2025

By Technology (Automation Technology, Digitization Technology), By Component (Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase), By Application (Clinical Phase, Drug Discovery Phase, Production Phase) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Automation In Biopharma Industry Market Overview

• Automation In Biopharma Industry market size has reached to $2.08 billion in 2024

• Expected to grow to $2.92 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%

• Growth Driver: Rising Role Of Robotics In Pharmaceutical Manufacturing Fuels Expansion Of Automation In The Biopharma Industry

• Market Trend: Innovative Technological Strides In The Automation Of Biopharma Industry

North America was the largest region in 2024.

What Is Covered Under Automation In Biopharma Industry Market?

Automation in the biopharma industry refers to integrating advanced technologies and robotics into various stages of the biopharmaceutical manufacturing process. It includes using automated systems and equipment to carry out tasks traditionally performed by humans, intending to increase efficiency, accuracy, and productivity in producing biopharmaceutical products.

The main technologies in automation in biopharma industry are automation technology and digitization technology. Automation technology refers to the use of various technologies, such as robotics, artificial intelligence (AI), and software systems, to automate and streamline processes and tasks that were traditionally performed by humans. It includes components such as automation hardware, automation software, service project phases, and service operation phases, that are used in applications including clinical phases, drug discovery phases, and production phases.

Automation In Biopharma Industry Market Size and growth rate 2025 to 2029: Graph

What Is The Automation In Biopharma Industry Market Size 2025 And Growth Rate?

The automation in biopharma industry market size has grown strongly in recent years. It will grow from $2.08 billion in 2024 to $2.19 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to increased complexity in biopharmaceutical processes, need for improved process efficiency, growth in biologics development and manufacturing, demand for quality assurance and control, pressure to reduce time-to-market

What Is The Automation In Biopharma Industry Market Growth Forecast?

The automation in biopharma industry market size is expected to see strong growth in the next few years. It will grow to $2.92 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to enhanced data integrity and documentation, rise of personalized medicine, rise of modular and flexible bioprocessing facilities, evolution of automation platforms, rising demand for biosimilars, adoption of smart sensors and internet of things (iot). Major trends in the forecast period include advances in robotics and automation technologies, advancements in single-use technologies, integration of artificial intelligence in bioprocessing, advances in process analytical technologies (pat), collaboration between biopharma and technology companies, emphasis on sustainability in biopharma automation.

The forecast of 7.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. drug manufacturing by inflating prices of modular cleanroom systems and automated fill-finish equipment developed in Germany and Singapore, resulting in production bottlenecks and higher biologic drug development costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Automation In Biopharma Industry Market Segmented?

1) By Technology: Automation Technology, Digitization Technology

2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase

3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase

Subsegments:

1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)

2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology

What Is Driving The Automation In Biopharma Industry Market? Rising Role Of Robotics In Pharmaceutical Manufacturing Fuels Expansion Of Automation In The Biopharma Industry

The increasing adoption of robots in pharmaceutical manufacturing is expected to propel the growth of automation in biopharma industry market. Robots in pharmaceutical manufacturing refer to advanced automated systems and machines that perform various tasks in producing and packaging pharmaceutical products. Robots are often used in multiple applications in pharmaceutical manufacturing, such as secondary packaging, intralogistics, laboratory automation, pick and place, automation of pharmacy processes, and personalized medicine, resulting in greater productivity, enhanced precision, reduced risk of contamination, and improved worker safety. For instance, in September 2024, according to the International Federation of Robotics, a Germany-based professional non-profit organization, industrial robot installations in manufacturing industry in Europe increased by 9%, reaching a record high of 92,393 units. Of these, 80% were installed within the European Union, totaling 73,534 units—a 2% rise from the previous year. Therefore, the increasing adoption of robots in pharmaceutical manufacturing will drive the growth of automation in biopharma industry industry.

What Is Driving The Automation In Biopharma Industry Market? Accelerated Drug Development Shapes The Future Of Biopharma Industry Automation

The increasing drug development is expected to boost the growth of automation in the biopharma industry market going forward. Drug development is the process of discovering and bringing a new pharmaceutical product to market. The drug development propels the biopharma industry automation, where automated systems streamline processes, expedite research, ensure precision, and enhance efficiency, becoming essential. For instance, in January 2023, according to a report published by the Food and Drug Administration, a US-based federal agency, the Center for Drug Evaluation and Research (CDER) granted approval to 37 new drugs in 2022 that had never been previously approved or marketed in the United States, categorically referred to as novel drugs. Of these 37 drugs, 20, accounting for 54%, received approval during the same year. Therefore, increasing drug development is driving the growth of automation in the biopharma industry market.

Who Are The Major Players In The Global Automation In Biopharma Industry Market?

Major companies operating in the automation in biopharma industry market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-TOLEDo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.

What Are The Key Trends Of The Global Automation In Biopharma Industry Market? Innovative Technological Strides In The Automation Of Biopharma Industry

Technological advancements are a key trend gaining popularity in the automation in biopharma industry market. Major companies operating in the automation in biopharma industry market are focused on developing advanced product technologies to strengthen their position in the market. For instance, in September 2022, PerkinElmer Inc., a US-based company providing scientific solutions and technologies, launched the Cellaca PLX Image Cytometry System, a cutting-edge automated cell analysis solution designed to simplify cell and gene therapy research and manufacturing. The Cellaca PLX platform allows researchers to evaluate critical quality attributes of cell samples, including identity, quantity, and quality, through an automated workflow. This integrated system combines image cytometer hardware, software, validated consumables, and trackable data reporting, simplifying calibration and training requirements.

What Are The Key Trends Of The Global Automation In Biopharma Industry Market? Automated Customer Data Platform (CDP) Revolutionizing The Industry

Major companies operating in the automation in biopharma industry market are developing advanced technologies, such as automated customer data platforms (CDP), to meet larger customer bases, increase sales, and increase revenue. An automated customer data platform (CDP) is a software solution designed to collect, organize, and analyze customer data from various sources in an automated and centralized manner. For instance, in July 2022, Tealium, a US-based provider of customer data orchestration tools, launched Tealium for Pharma. Tealium for Pharma stands out with its verticalized platform, meticulously crafted to fully automate and enhance the customer experience for Pharma audiences. It uniquely addresses the challenges posed by the industry's dynamic privacy and security regulations. In contrast to the fragmented silos often seen in data analysis and privacy compliance within pharma companies, Tealium's data-first offering integrates and automates data seamlessly. This results in an elevated customer experience across numerous touch points, spanning every channel in real-time, all while maintaining the highest standards of Health Insurance Portability and Accountability Act (HIPAA) compliance.

Need data on a specific region in this market?

Automation In Biopharma Industry Market Merger And Acquisition: Bruker Corporation Acquired Optimal Industrial Automation Limited

In April 2022, Bruker Corporation, a US-based company engaged in scientific instruments for molecular and materials research, acquired Optimal Industrial Automation Limited for an undisclosed amount. The acquisition strengthens Bruker as a key software and solutions provider for small molecule, biologic, and new drug modalities pharma companies. Optimal Industrial Automation Limited is a UK-based company that provides pharmaceutical and biopharmaceutical automation solutions, including process analytical technology (PAT), manufacturing automation, quality assurance (QA) software, and systems integration.

Regional Outlook For The Global Automation In Biopharma Industry Market

North America was the largest region in the automation in biopharma industry market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the Automation In Biopharma Industry Market?

The automation in biopharma industry market consists of revenues earned by entities by providing high-throughput screening, sample management, and cell culture automation used during the process. The market value includes the value of related goods sold by the service provider or included within the service offering. The automation in biopharma industry market also includes sales of automated dissolution testing systems, robotic sample storage and retrieval systems, and chromatography systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Automation In Biopharma Industry Industry?

The automation in biopharma industry market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the automation in biopharma industry industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Automation In Biopharma Industry Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $2.19 billion
Revenue Forecast In 2034 $2.92 billion
Growth Rate CAGR of 7.4% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Technology: Automation Technology, Digitization Technology
2) By Component: Automation Hardware, Automation Software, Services Project Phase, Services Operation Phase
3) By Application: Clinical Phase, Drug Discovery Phase, Production Phase Subsegments: 1) By Automation Technology: Process Automation, Laboratory Automation, Robotics And Artificial Intelligence, Control Systems, Programmable Logic Controllers (PLCs)
2) By Digitization Technology: Data Analytics And Visualization, Electronic Lab Notebooks (ELN), Cloud Computing, Internet Of Things (IoT) In Pharma, Digital Twin Technology
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Automation In Biopharma Industry Market Characteristics

3. Automation In Biopharma Industry Market Trends And Strategies

4. Automation In Biopharma Industry Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Automation In Biopharma Industry Growth Analysis And Strategic Analysis Framework

5.1. Global Automation In Biopharma Industry PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Automation In Biopharma Industry Market Growth Rate Analysis

5.4. Global Automation In Biopharma Industry Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Automation In Biopharma Industry Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Automation In Biopharma Industry Total Addressable Market (TAM)

6. Automation In Biopharma Industry Market Segmentation

6.1. Global Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Automation Technology

Digitization Technology

6.2. Global Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Automation Hardware

Automation Software

Services Project Phase

Services Operation Phase

6.3. Global Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clinical Phase

Drug Discovery Phase

Production Phase

6.4. Global Automation In Biopharma Industry Market, Sub-Segmentation Of Automation Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Process Automation

Laboratory Automation

Robotics And Artificial Intelligence

Control Systems

Programmable Logic Controllers (PLCs)

6.5. Global Automation In Biopharma Industry Market, Sub-Segmentation Of Digitization Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Data Analytics And Visualization

Electronic Lab Notebooks (ELN)

Cloud Computing

Internet Of Things (IoT) In Pharma

Digital Twin Technology

7. Automation In Biopharma Industry Market Regional And Country Analysis

7.1. Global Automation In Biopharma Industry Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Automation In Biopharma Industry Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Automation In Biopharma Industry Market

8.1. Asia-Pacific Automation In Biopharma Industry Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Automation In Biopharma Industry Market

9.1. China Automation In Biopharma Industry Market Overview

9.2. China Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Automation In Biopharma Industry Market

10.1. India Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Automation In Biopharma Industry Market

11.1. Japan Automation In Biopharma Industry Market Overview

11.2. Japan Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Automation In Biopharma Industry Market

12.1. Australia Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Automation In Biopharma Industry Market

13.1. Indonesia Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Automation In Biopharma Industry Market

14.1. South Korea Automation In Biopharma Industry Market Overview

14.2. South Korea Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Automation In Biopharma Industry Market

15.1. Western Europe Automation In Biopharma Industry Market Overview

15.2. Western Europe Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Automation In Biopharma Industry Market

16.1. UK Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Automation In Biopharma Industry Market

17.1. Germany Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Automation In Biopharma Industry Market

18.1. France Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Automation In Biopharma Industry Market

19.1. Italy Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Automation In Biopharma Industry Market

20.1. Spain Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Automation In Biopharma Industry Market

21.1. Eastern Europe Automation In Biopharma Industry Market Overview

21.2. Eastern Europe Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Automation In Biopharma Industry Market

22.1. Russia Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Automation In Biopharma Industry Market

23.1. North America Automation In Biopharma Industry Market Overview

23.2. North America Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Automation In Biopharma Industry Market

24.1. USA Automation In Biopharma Industry Market Overview

24.2. USA Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Automation In Biopharma Industry Market

25.1. Canada Automation In Biopharma Industry Market Overview

25.2. Canada Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Automation In Biopharma Industry Market

26.1. South America Automation In Biopharma Industry Market Overview

26.2. South America Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Automation In Biopharma Industry Market

27.1. Brazil Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Automation In Biopharma Industry Market

28.1. Middle East Automation In Biopharma Industry Market Overview

28.2. Middle East Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Automation In Biopharma Industry Market

29.1. Africa Automation In Biopharma Industry Market Overview

29.2. Africa Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Automation In Biopharma Industry Market Competitive Landscape And Company Profiles

30.1. Automation In Biopharma Industry Market Competitive Landscape

30.2. Automation In Biopharma Industry Market Company Profiles

30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.4. ABB Ltd Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Automation In Biopharma Industry Market Other Major And Innovative Companies

31.1. Emerson Electric Co.

31.2. Becton Dickinson and Company (BD)

31.3. Corning Incorporated

31.4. Rockwell Automation Inc.

31.5. Agilent Technologies Inc.

31.6. PerkinElmer Inc.

31.7. Sartorius AG

31.8. bioMérieux SA

31.9. Mettler-Toledo International Inc.

31.10. Beckman Coulter Inc.

31.11. Waters Corporation

31.12. Pall Corporation

31.13. Bruker Corporation

31.14. Qiagen N.V.

31.15. Eppendorf AG

32. Global Automation In Biopharma Industry Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Automation In Biopharma Industry Market

34. Recent Developments In The Automation In Biopharma Industry Market

35. Automation In Biopharma Industry Market High Potential Countries, Segments and Strategies

35.1 Automation In Biopharma Industry Market In 2029 - Countries Offering Most New Opportunities

35.2 Automation In Biopharma Industry Market In 2029 - Segments Offering Most New Opportunities

35.3 Automation In Biopharma Industry Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Automation In Biopharma Industry Market, Sub-Segmentation Of Automation Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Automation In Biopharma Industry Market, Sub-Segmentation Of Digitization Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Automation In Biopharma Industry Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Automation In Biopharma Industry Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Indonesia, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: South Korea, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Western Europe, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: UK, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Germany, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: France, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Italy, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Spain, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Eastern Europe, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Russia, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: North America, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: USA, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Canada, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: South America, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Brazil, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Middle East, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Africa, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 77: Thermo Fisher Scientific Inc. Financial Performance
  • Table 78: Danaher Corporation Financial Performance
  • Table 79: ABB Ltd Financial Performance
  • Table 80: Siemens Healthineers AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Automation In Biopharma Industry Market, Sub-Segmentation Of Automation Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Automation In Biopharma Industry Market, Sub-Segmentation Of Digitization Technology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Automation In Biopharma Industry Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Automation In Biopharma Industry Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Indonesia, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: South Korea, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Western Europe, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: UK, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Germany, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: France, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Italy, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Spain, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Eastern Europe, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Russia, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: North America, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: USA, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Canada, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: South America, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Brazil, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Middle East, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Africa, Automation In Biopharma Industry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Automation In Biopharma Industry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Automation In Biopharma Industry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 77: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 78: Danaher Corporation Financial Performance
  • Figure 79: ABB Ltd Financial Performance
  • Figure 80: Siemens Healthineers AG Financial Performance

Frequently Asked Questions

Automation in the biopharma industry refers to integrating advanced technologies and robotics into various stages of the biopharmaceutical manufacturing process. It includes using automated systems and equipment to carry out tasks traditionally performed by humans, intending to increase efficiency, accuracy, and productivity in producing biopharmaceutical products. For further insights on this market, request a sample here

The market major growth driver - Rising Role Of Robotics In Pharmaceutical Manufacturing Fuels Expansion Of Automation In The Biopharma Industry. For further insights on this market, request a sample here

The automation in biopharma industry market size has grown strongly in recent years. It will grow from $2.08 billion in 2024 to $2.19 billion in 2025 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to increased complexity in biopharmaceutical processes, need for improved process efficiency, growth in biologics development and manufacturing, demand for quality assurance and control, pressure to reduce time-to-market. The automation in biopharma industry market size is expected to see strong growth in the next few years. It will grow to " $2.92 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to enhanced data integrity and documentation, rise of personalized medicine, rise of modular and flexible bioprocessing facilities, evolution of automation platforms, rising demand for biosimilars, adoption of smart sensors and internet of things (iot). Major trends in the forecast period include advances in robotics and automation technologies, advancements in single-use technologies, integration of artificial intelligence in bioprocessing, advances in process analytical technologies (pat), collaboration between biopharma and technology companies, emphasis on sustainability in biopharma automation. For further insights on this market, request a sample here

The automation in biopharma industrymarket covered in this report is segmented –
1) By Technology: Automation Technology; Digitization Technology
2) By Component: Automation Hardware; Automation Software; Services Project Phase; Services Operation Phase
3) By Application: Clinical Phase; Drug Discovery Phase; Production Phase Subsegments:
1) By Automation Technology: Process Automation; Laboratory Automation; Robotics And Artificial Intelligence; Control Systems; Programmable Logic Controllers (PLCs)
2) By Digitization Technology: Data Analytics And Visualization; Electronic Lab Notebooks (ELN); Cloud Computing; Internet Of Things (IoT) In Pharma; Digital Twin Technology For further insights on this market,
request a sample here

North America was the largest region in the automation in biopharma industry market in 2024. The regions covered in the automation in biopharma industry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the automation in biopharma industry market include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, ABB Ltd, Siemens Healthineers AG, Emerson Electric Co., Becton Dickinson and Company (BD), Corning Incorporated, Rockwell Automation Inc., Agilent Technologies Inc., PerkinElmer Inc., Sartorius AG, bioMérieux SA, Mettler-Toledo International Inc., Beckman Coulter Inc., Waters Corporation, Pall Corporation, Bruker Corporation, Qiagen N.V., Eppendorf AG, Tecan Group Ltd., Promega Corporation, Brooks Automation Inc., Omron Automation, Hamilton Company, Integra Biosciences AG, Gilson Inc., Analytik Jena AG, BioTek Instruments Inc. . For further insights on this market, request a sample here.

Major trends in this market include Innovative Technological Strides In The Automation Of Biopharma Industry. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon